This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Friday, April 29 • 6:00am - 7:30am
EGFR Mutation-Positive Metastatic NSCLC: A First Step in Choosing the Right Treatment for the Right Patient*

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This promotional non-CNE symposium, sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., will provide an opportunity to learn more about metastatic NSCLC with common EGFR mutations, including biomarker testing, treatment options, and supportive care via clinical case studies.  

This program is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.

Friday April 29, 2016 6:00am - 7:30am CDT
Grand Hyatt, Lonestar Ballroom ABC